PortfoliosLab logo

Aziyo Biologics, Inc. (AZYO)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Aziyo Biologics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,014 for a total return of roughly -89.86%. All prices are adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2023FebruaryMarch
-89.86%
15.21%
AZYO (Aziyo Biologics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AZYO

Aziyo Biologics, Inc.

Return

Aziyo Biologics, Inc. had a return of -65.41% year-to-date (YTD) and -70.36% in the last 12 months. Over the past 10 years, Aziyo Biologics, Inc. had an annualized return of -60.68%, while the S&P 500 had an annualized return of 5.94%, indicating that Aziyo Biologics, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-67.37%-0.66%
Year-To-Date-65.41%3.42%
6 months-78.32%5.67%
1 year-70.36%-10.89%
5 years (annualized)-60.68%5.94%
10 years (annualized)-60.68%5.94%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20235.53%-7.98%
2022-1.37%13.19%-15.34%-38.41%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aziyo Biologics, Inc. Sharpe ratio is -0.67. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50NovemberDecember2023FebruaryMarch
-0.67
-0.47
AZYO (Aziyo Biologics, Inc.)
Benchmark (^GSPC)

Dividend History


Aziyo Biologics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-91.04%
-17.21%
AZYO (Aziyo Biologics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aziyo Biologics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aziyo Biologics, Inc. is 92.75%, recorded on Mar 22, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.75%Feb 4, 2021536Mar 22, 2023
-25.72%Oct 9, 202021Nov 6, 202018Dec 3, 202039
-16.6%Dec 4, 20209Dec 16, 202019Jan 14, 202128
-7.75%Jan 15, 20212Jan 19, 20211Jan 20, 20213
-5.22%Jan 21, 20211Jan 21, 20212Jan 25, 20213
-4.33%Feb 1, 20212Feb 2, 20211Feb 3, 20213
-1.19%Jan 26, 20211Jan 26, 20213Jan 29, 20214

Volatility Chart

Current Aziyo Biologics, Inc. volatility is 539.66%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%NovemberDecember2023FebruaryMarch
539.66%
19.50%
AZYO (Aziyo Biologics, Inc.)
Benchmark (^GSPC)